HospitalsAescia for Hospitals is an investigational Software as a Medical Device under the TGA Class IIa pathway. Not yet available for commercial supply.
ClinicsAescia for Clinics is a workflow and patient-preparation tool. It does not propose clinical decisions and is not a medical device.
A platform for structured patient follow-up, built for hospitals and specialty clinics.
Aescia hosts customer data in the customer's jurisdiction on Google Cloud and signs the relevant data agreement (BAA in the US, DPA under the GDPR, the equivalent under the Australian Privacy Principles or PIPEDA) before any patient data is exchanged. SOC 2 path opens with the first design-partner contract.
Read the security packAescia is pre-first-customer and says so plainly. A clinic can start with manual data entry or a simple export, with no integration required to begin. Any deeper data exchange with your systems is scoped with you.
How we start with youInteractive ROI calculator with conservative, expected, and better-case bands anchored to Beran 2024 (n=358,257), Allen 2023 ASC facility fees, and Mehta 2021 intervention outcomes. No point estimates. Assumptions are visible.
Open the calculatorA small named set of ASCs. Outcomes pre-specified in writing before the pilot starts, measured against the customer's own historical data, adjudicated by the customer's QA committee. Commercial terms negotiated per deal.
Read the program termsA structured follow-up layer for cardiothoracic surgery and other high-acuity discharges. Daily patient check-ins, transparent rule-based prioritisation, one prioritised clinical list for the nursing team.
Aescia for HospitalsPre-procedure pathways for endoscopy and other specialty clinics. Multichannel reach by SMS and email into a patient web-app, diabetic, anticoagulant, and GLP-1 overlays, recall management, fewer phone calls to the front desk.
Aescia for ClinicsEvery Aescia pathway is a sequence of five step types: Collect a structured signal, Follow a clinician-authored rule, Remind the patient, Educate at the right moment, Export the structured record. We build the engine once and apply it to the two moments where care most often falls apart: the week after discharge, and the week before a scheduled procedure.
Structured patient signal. Photo, scale, questionnaire, vitals, timestamped.
A clinician-authored rule reads the signal and decides. Every rule explainable.
Timed outbound prompt by SMS, email, or in-app, in the patient's language.
A clinician-written PDF, video, or card delivered at the right moment.
A structured, consented, time-stamped record ready for the patient's chart.
One engine · five step types · every pathway
Structured patient signal. Photo, scale, questionnaire, vitals, timestamped.
A clinician-authored rule reads the signal and decides. Every rule explainable.
Timed outbound prompt by SMS, email, or in-app, in the patient's language.
A clinician-written PDF, video, or card delivered at the right moment.
A structured, consented, time-stamped record ready for the patient's chart.
Rule-based prioritisation, authored by clinicians. No opaque models. Every flag is explainable to the nurse it lands with and to the committee that asks.
Pathways are written by practising surgeons, gastroenterologists, and nurses. We do not ship a disease we did not learn from the people who treat it.
A regulated pathway for surgical recovery and a workflow pathway for procedural clinics share the same authoring layer, the same audit trail, the same team.
The SAFE-Discharge trial is a single-centre evaluation of Aescia for post-cardiothoracic-surgery discharge monitoring at the Royal Prince Alfred Hospital cardiothoracic unit in Sydney. A 50-patient interim cohort is pre-specified, followed by a 500-patient main cohort, 550 patients total. Led by Dr Kei Woldendorp, Principal Investigator. Aescia for Hospitals has an intended Class IIa classification under TGA Rule 3.4; a regulatory submission is in preparation. Aescia for Clinics is a workflow tool that does not propose clinical decisions and is not a medical device.
Read the evidence pageAescia runs its clinical programme through the Royal Prince Alfred Hospital cardiothoracic unit in Sydney, with research collaborations across named institutes in Australia and Canada. We publish affiliations we have earned, not logo walls.
Royal Prince Alfred Hospital
Sydney Local Health District tertiary teaching hospital. Cardiothoracic surgical unit hosts the SAFE-Discharge trial site (550 patients).
(opens in a new window)The Baird Institute
Independent cardiothoracic surgical research institute affiliated with RPAH. Co-investigator on SAFE-Discharge.
(opens in a new window)Institute of Academic Surgery
RPAH academic surgery research and education hub. Provides governance pathway for the SAFE-Discharge implementation evaluation.
(opens in a new window)CHEO Research Institute
Children's Hospital of Eastern Ontario research arm in Ottawa. Aescia is a selected participant in its Product-Market-Fit (PMF) programme, working on a paediatric respiratory post-discharge pathway.
(opens in a new window)District 3
Quebec's leading bio/health/tech startup incubator at Concordia University, Montréal. Aescia portfolio company since September 2025.
(opens in a new window)MTAA MedTech Compass
Medical Technology Association of Australia capability programme for emerging medical-device companies. Aescia industry member.
(opens in a new window)A thirty-minute call with someone on the clinical team. We show the worklist, the pathway editor, and what the week after surgery or the night before a colonoscopy actually looks like.
Request a briefing